Skip to content

Comparison of postoperative analgesia following i.v. patient-controlled analgesia (PCA) versus femoral catheter PCA after Arthroscopic Anterior Cruciate Ligamentum (ACL) repair

Comparison of postoperative analgesia following i.v. patient-controlled analgesia (PCA) versus femoral catheter PCA after Arthroscopic Anterior Cruciate Ligamentum (ACL) repair

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901182366N2
Enrollment
70
Registered
2010-04-20
Start date
2007-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Tear of meniscus, current. Condition 2: Opioids and related analgesics. Condition 3: Local anaesthetics. Condition 4: Pain in joint. Tear of meniscus, current Opioids and related analgesics Local anaesthetics Pain in joint

Interventions

Intervention 1: Intervention group: After postoperative femoral nerve block in the recovery room and catheter insertion, PCRA pump contain Bupivacaine %0.1 was connected to the femoral catheter. Inter
Treatment - Other
Treatment - Drugs
Intervention group: After postoperative femoral nerve block in the recovery room and catheter insertion, PCRA pump contain Bupivacaine %0.1 was connected to the femoral catheter
Control group: PCA contain morphie 0.2 mg/ml was connectd to iv line.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1) patient who candidated for ACL surgery, 2) aged 20-50 yrs, 3) ASA physical status I, II. Exclusion Criteria: 1) presence of coexisting diseases (coagulative, seizure, cardiac, ...), 2) history of smoking, opioid and alchohol addiction, 3) allergy to morphine or local anesthetic, 4) patient refusal .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative analgesia. Timepoint: every 8 hrs. Method of measurement: Visual analoque scale.

Secondary

MeasureTime frame
Complications. Timepoint: every 8 hrs. Method of measurement: patient evaluation and observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnad Imani

Iran University of Medical Sciences

farimani@iums.ac.ir+98 21 6651 5758

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026